New Horizons Medical Appoints Dr. Ximena Sanchez as Chief Medical Officer (CMO)
FRAMINGHAM, MA / ACCESS Newswire / January 21, 2025 / New Horizons Medical (NHM), a leader in healthcare for dually...
Year: 2025
STR Behavioral Health Expands Addiction and Mental Health Treatment in Pennsylvania with Outpatient Clinic in Lancaster
Established Program Broadens Its Range of Services to Meet the Growing Demand for High-Quality Substance Use Disorder and Mental Health...
HGHmeds Brings Safety and Efficiency to the Expanding Global HGH Market
The Mexico-based hormone clinic, which has online capabilities is doing its part to meet increased global demand for affordable Human...
HGHmeds Brings Safety and Efficiency to the Expanding Global HGH Market
The Mexico-based hormone clinic, which has online capabilities is doing its part to meet increased global demand for affordable Human...
PharmaCord Announces Appointment of Robert Truckenmiller as CEO
JEFFERSONVILLE, INDIANA / ACCESS Newswire / January 21, 2025 / PharmaCord LLC, a leading provider of patient services for the...
PharmaCord Announces Appointment of Robert Truckenmiller as CEO
JEFFERSONVILLE, INDIANA / ACCESS Newswire / January 21, 2025 / PharmaCord LLC, a leading provider of patient services for the...
The 2025 Black Book of Behavioral Health IT Released: A Competitive Intelligence Report
Free to participants in the 2025 survey of BHIT software, this comprehensive report offers critical insights into trends, developments, and...
The 2025 Black Book of Behavioral Health IT Released: A Competitive Intelligence Report
Free to participants in the 2025 survey of BHIT software, this comprehensive report offers critical insights into trends, developments, and...
Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT
FORT LAUDERDALE, FL / ACCESS Newswire / January 21, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company...
Sonnet BioTherapeutics Expands Phase 1 SB101 Trial to Evaluate Combination of SON-1010 with Trabectedin in Certain Sarcomas
SON-1010, after receipt of data suggesting clinical benefit when administered as a monotherapy in patients with advanced solid tumors, enters...
Yerbae Expands Midwest Convenience Store Presence with Casey’s General Stores Authorization
SCOTTSDALE, Ariz., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Yerbaé Brands Corp. (TSX-V: YERB.U; OTCQX: YERBF) (“Yerbaé” or the “Company”), a...
Dermata and Revance Enter Clinical Trial Collaboration Agreement for the Topical Application of Xyngari(TM) with Daxxify(R)
The Companies intend to first initiate a Phase 2a clinical trial evaluating Xyngari™ with Daxxify® to treat primary axillary hyperhidrosis...
Scilex Holding Company Announces that Its Note Holders Intend to Participate in the Funding and Licensing of Gloperba® Ex-U.S. Commercialization Rights from Romeg Therapeutics, LLC
PALO ALTO, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating...
Heidi Kling: Transforming Mental Health Care Through Advocacy and Action
NEW YORK CITY, NY / ACCESS Newswire / January 21, 2025 / In an era where mental health challenges continue...
Nacuity Pharmaceuticals Granted U.S. FDA Fast Track Designation for NPI-001 (N-acetylcysteine amide) Tablets for the Treatment of Retinitis Pigmentosa
FORT WORTH, Texas, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Nacuity Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing treatments for retinitis...
NeurAxis Announces New Medical Policy Coverage with Molina Healthcare for Over Five Million Lives Across Multiple States
CARMEL, Ind., Jan. 21, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology...
Olympia Pharmaceuticals Expands into Alabama with New Licensing, Bringing GLP-1s and More to Healthcare Providers
Nation’s leading compound pharmacy is now available in 48 statesORLANDO, Fla., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Olympia Pharmaceuticals, a...
Welcoming Victor Bornsztejn as Senior Vice President of Commercial
SAN FRANCISCO, CALIFORNIA, UNITED STATES, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Culture Biosciences, a leader in cloud-connected bioprocessing technologies, is...
Shuttle Pharma Reaches Milestone in Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
GAITHERSBURG, Md., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development...
Completion of Offering and Increase in Registered Capital
TOKYO, Jan. 21, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (the “Company” or “MEDIROM”), a health technology...